Literature DB >> 19797403

Sphingosine kinase as a regulator of calcium entry through autocrine sphingosine 1-phosphate signaling in thyroid FRTL-5 cells.

Dan Gratschev1, Christoffer Löf, Jari Heikkilä, Anders Björkbom, Pramod Sukumaran, Ari Hinkkanen, J Peter Slotte, Kid Törnquist.   

Abstract

Calcium entry is one of the main regulators of intracellular signaling. Here, we have described the importance of sphingosine, sphingosine kinase 1 (SK1), and sphingosine 1-phosphate (S1P) in regulating calcium entry in thyroid FRTL-5 cells. In cells incubated with the phosphatase inhibitor calyculin A, which evokes calcium entry without mobilizing sequestered intracellular calcium, sphingosine inhibited calcium entry in a concentration-dependent manner. Furthermore, inhibiting SK1 or the ATP-binding cassette ABCC1 multidrug transporter attenuated calcium entry. The addition of exogenous S1P restored calcium entry. Neither sphingosine nor inhibition of SK1 attenuated thapsigargin-evoked calcium entry. Blocking S1P receptor 2 or phospholipase C attenuated calcium entry, whereas blocking S1P receptor 3 did not. Overexpression of wild-type SK1, but not SK2, enhanced calyculin-evoked calcium entry compared with mock-transfected cells, whereas calcium entry was decreased in cells transfected with the dominant-negative G82D SK1 mutant. Exogenous S1P restored calcium entry in G82D cells. Our results suggest that the calcium entry pathway is blocked by sphingosine and that activation of SK1 and the production of S1P, through an autocrine mechanism, facilitate calcium entry through activation of S1P receptor 2. This is a novel mechanism by which the sphingosine-S1P rheostat regulates cellular calcium homeostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797403     DOI: 10.1210/en.2009-0288

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel.

Authors:  Parker C Wilson; Wayne R Fitzgibbon; Sara M Garrett; Ayad A Jaffa; Louis M Luttrell; Michael W Brands; Hesham M El-Shewy
Journal:  Mol Endocrinol       Date:  2015-04-14

2.  Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphingolipid and VEGF Receptor Expression: IMPLICATIONS FOR THYROID CANCER CELL MIGRATION AND PROLIFERATION.

Authors:  Muhammad Yasir Asghar; Melissa Magnusson; Kati Kemppainen; Pramod Sukumaran; Christoffer Löf; Ilari Pulli; Veronica Kalhori; Kid Törnquist
Journal:  J Biol Chem       Date:  2015-05-13       Impact factor: 5.157

3.  Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate.

Authors:  Deanna L Siow; Charles D Anderson; Evgeny V Berdyshev; Anastasia Skobeleva; Stuart M Pitson; Binks W Wattenberg
Journal:  J Lipid Res       Date:  2010-04-12       Impact factor: 5.922

4.  Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640.

Authors:  James W Antoon; Martin D White; William D Meacham; Evelyn M Slaughter; Shannon E Muir; Steven Elliott; Lyndsay V Rhodes; Hasina B Ashe; Thomas E Wiese; Charles D Smith; Matthew E Burow; Barbara S Beckman
Journal:  Endocrinology       Date:  2010-09-22       Impact factor: 4.736

5.  Sphingosine kinase 1 isoform-specific interactions in breast cancer.

Authors:  Daniel Yagoub; Marc R Wilkins; Angelina J Lay; Dominik C Kaczorowski; Diana Hatoum; Sarah Bajan; Gyorgy Hutvagner; Jack H Lai; Wengen Wu; Rosetta Martiniello-Wilks; Pu Xia; Eileen M McGowan
Journal:  Mol Endocrinol       Date:  2014-09-12

Review 6.  Uncovering the 'sphinx' of sphingosine 1-phosphate signalling: from cellular events to organ morphogenesis.

Authors:  Mengqiao Cui; Verena Göbel; Hongjie Zhang
Journal:  Biol Rev Camb Philos Soc       Date:  2021-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.